{"id":"CHEMBL1020","canonicalSmiles":"Cc1ccc(C(=O)c2ccc(CC(=O)O)n2C)cc1","inchiKey":"UPSPUYADGBWSHF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"TOLMETIN","yearOfFirstApproval":1976,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["MCN-2559","Tolectin","Tolmetin"],"crossReferences":{"DailyMed":["tolmetin%20sodium"],"Wikipedia":["Tolmetin"],"drugbank":["DB00500"],"chEBI":["71941"]},"childChemblIds":["CHEMBL1556918","CHEMBL1200613","CHEMBL1437585"],"count":3,"approvedIndications":["HP_0002829","HP_0003326","EFO_0005755"],"linkedTargets":{"rows":["ENSG00000073756","ENSG00000095303"],"count":2},"linkedDiseases":{"rows":["HP_0002829","HP_0003326","EFO_0005755"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1976 and has 3 approved indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1081312","canonicalSmiles":"Nc1ncnc2c1c(-c1cnc3[nH]ccc3c1)nn2C1CCCC1","inchiKey":"NVRXTLZYXZNATH-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1081312","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["103904782"],"drugbank":["DB08052"],"chEBI":["50915"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1136","canonicalSmiles":"CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C","inchiKey":"LJVAJPDWBABPEJ-PNUFFHFMSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"TELITHROMYCIN","yearOfFirstApproval":2004,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Ketek"],"synonyms":["HMR 3647","HMR-3647","Ketek","Telithromycin"],"crossReferences":{"DailyMed":["telithromycin"],"PubChem":["144205007","144205756"],"Wikipedia":["Telithromycin"],"drugbank":["DB00976"]},"count":7,"approvedIndications":["EFO_0003106","EFO_0000771","EFO_0000544"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2004 and has 3 approved and 4 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL114500","canonicalSmiles":"COc1ccnc(NC2CCN(C(=O)c3ccc(C#N)cc3)CC2)c1","inchiKey":"SZUVGMCKKLJAFX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AR-C133057XX","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AR-C133057XX"],"crossReferences":{"drugbank":["DB07002"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1200332","canonicalSmiles":"CNCCCC1c2ccccc2C=Cc2ccccc21.Cl","inchiKey":"OGQDIIKRQRZXJH-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"PROTRIPTYLINE HYDROCHLORIDE","yearOfFirstApproval":1967,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL668","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Concordin-10","Concordin-5","Protriptyline hydrochloride","Vivactil"],"synonyms":["MK-240","Protriptyline hydrochloride"],"crossReferences":{"DailyMed":["protriptyline%20hydrochloride"],"PubChem":["144203795","170465077","50106858","50106859","56422215","855990"],"chEBI":["8598"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1967. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1200468","canonicalSmiles":"CCOC(=O)CC(SP(=S)(OC)OC)C(=O)OCC","inchiKey":"JXSJBGJIGXNWCI-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MALATHION","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Cythion","Derbac-m","Malathion","Organoderm","Ovide","Prioderm","Quellada-m","Suleo-m"],"synonyms":["8059HC","ENT 17,034","ENT-17034","Malathion","NSC-6524","OVIDE"],"crossReferences":{"DailyMed":["malathion"],"PubChem":["144214009","170465311","17389839","26753130","26753131","50105655"],"Wikipedia":["Malathion"],"drugbank":["DB00772"],"chEBI":["6651"]},"count":2,"approvedIndications":["EFO_0001067"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1982 and is indicated for parasitic infection and has 1 investigational indication."}
{"id":"CHEMBL1200549","canonicalSmiles":"C=CC[N+]1([C@H]2C[C@H]3[C@@H]4CC[C@H]5C[C@H](OC(C)=O)[C@@H](N6CCCCC6)C[C@]5(C)[C@H]4CC[C@]3(C)[C@H]2OC(=O)CC)CCCCC1.[Br-]","inchiKey":"LVQTUXZKLGXYIU-GWSNJHLMSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"RAPACURONIUM BROMIDE","yearOfFirstApproval":1999,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1201352","hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["United States"],"classes":["Respiratory toxicity"],"year":2001},"tradeNames":["Raplon"],"synonyms":["ORG 9487","ORG-9487","Rapacuronium bromide"],"crossReferences":{"PubChem":["144206855"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1999. It was withdrawn in United States  in 2001 due to Respiratory toxicity."}
{"id":"CHEMBL1200609","canonicalSmiles":"CS(=O)(=O)O.Fc1ccc([C@@H]2CCNC[C@H]2COc2ccc3c(c2)OCO3)cc1","inchiKey":"SHIJTGJXUHTGGZ-RVXRQPKJSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"PAROXETINE MESYLATE","yearOfFirstApproval":2003,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL490","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Brisdelle","Pexeva"],"synonyms":["PO-T.MES","POT.MES","Paroxetine mesilate","Paroxetine mesylate","Paroxetine methanesulfonate"],"crossReferences":{"DailyMed":["paroxetine%20mesylate"]},"count":2,"linkedTargets":{"rows":["ENSG00000108576"],"count":1},"linkedDiseases":{"rows":["HP_0031217","EFO_0003922"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2003 and has 2 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1200729","canonicalSmiles":"O=C([O-])CCC(=O)OC[C@@H](NC(=O)C(Cl)Cl)[C@H](O)c1ccc([N+](=O)[O-])cc1.[Na+]","inchiKey":"RPLOPBHEZLFENN-HTMVYDOJSA-M","drugType":"Small molecule","blackBoxWarning":true,"name":"CHLORAMPHENICOL SODIUM SUCCINATE","yearOfFirstApproval":1959,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1201281","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Chloramphenicol sodium succinate","Chloromyccetin Sod Succ","Chloromycetin","Mychel-s","Paraxin","Protophenicol"],"synonyms":["Chloramphenicol monosuccinate sodium salt","Chloramphenicol sodium succinate"],"crossReferences":{"DailyMed":["chloramphenicol%20sodium%20succinate"],"PubChem":["144207033","170465429"]},"count":4,"approvedIndications":["EFO_0000771","EFO_1001888","EFO_0003894"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1959 and has 3 approved and 1 investigational indication. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1200800","canonicalSmiles":"CC(=O)[O-].CC(=O)[O-].[Ca+2]","inchiKey":"VSGNNIFQASZAOI-UHFFFAOYSA-L","drugType":"Small molecule","blackBoxWarning":false,"name":"CALCIUM ACETATE","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Calcium acetate","Eliphos","Everose","Phosex","Phoslo","Phoslo gelcaps","Phoslyra","Renacet"],"synonyms":["Calcium acetate","E-263","E263","FEMA NO. 2228","INS NO.263","INS-263"],"crossReferences":{"DailyMed":["calcium%20acetate"],"DrugCentral":["4287"],"Wikipedia":["Calcium_acetate"],"drugbank":["DB00258"],"chEBI":["3310"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1982 and has 1 investigational indication."}
{"id":"CHEMBL1200844","canonicalSmiles":"CC(=O)O.C[C@H]1C[C@H]2[C@@H]3CC[C@](O)(C(=O)CO)[C@@]3(C)C[C@H](O)[C@@H]2[C@@]2(C)C=CC(=O)C=C12","inchiKey":"MGVGMXLGOKTYKP-ZFOBEOMCSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"METHYLPREDNISOLONE ACETATE","maximumClinicalTrialPhase":0,"parentId":"CHEMBL650","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Depmedalone","Depo-Medrol","Medrol Acetate","Methylprednisolone Acetate"],"synonyms":[],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1200987","canonicalSmiles":"CCCCc1ncc(/C=C(\\Cc2cccs2)C(=O)O)n1Cc1ccc(C(=O)O)cc1.CS(=O)(=O)O","inchiKey":"DJSLTDBPKHORNY-XMMWENQYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"EPROSARTAN MESYLATE","yearOfFirstApproval":1997,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL813","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Eprosartan mesylate","Teveten"],"synonyms":["Eprosartan mesilate","Eprosartan mesylate","Eprosartan monomethanesulfonate","SK&F 108566-J","SK&F-108566-J"],"crossReferences":{"DailyMed":["eprosartan%20mesylate"],"PubChem":["144205739","170465071"],"chEBI":["48409"]},"count":2,"approvedIndications":["EFO_0000537"],"linkedTargets":{"rows":["ENSG00000144891"],"count":1},"linkedDiseases":{"rows":["EFO_1002032","EFO_0000537"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1997 and is indicated for hypertension and has 1 investigational indication. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1201295","canonicalSmiles":"Cc1ccc(C(=O)Oc2ccc(C(O)CNC(C)(C)C)cc2OC(=O)c2ccc(C)cc2)cc1","inchiKey":"FZGVEKPRDOIXJY-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BITOLTEROL","yearOfFirstApproval":1984,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Bitolterol"],"crossReferences":{"PubChem":["170465239"],"Wikipedia":["Bitolterol"],"drugbank":["DB00901"],"chEBI":["3133"]},"childChemblIds":["CHEMBL1200405"],"count":1,"approvedIndications":["HP_0006536"],"linkedTargets":{"rows":["ENSG00000169252"],"count":1},"linkedDiseases":{"rows":["HP_0006536"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1984 and is indicated for airway obstruction."}
{"id":"CHEMBL1201490","drugType":"Protein","blackBoxWarning":false,"name":"SERMORELIN ACETATE","yearOfFirstApproval":1990,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Geref"],"synonyms":["Sermorelin","Sermorelin acetate"],"crossReferences":{"Wikipedia":["Sermorelin"]},"description":"Protein drug with a maximum clinical trial phase of IV that was first approved in 1990."}
{"id":"CHEMBL1201539","drugType":"Protein","blackBoxWarning":false,"name":"INSULIN PORK","yearOfFirstApproval":1966,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Iletin i","Insulin","Regular insulin"],"synonyms":["Insulin porcine","Insulin porcine insulin","Insulin pork"],"crossReferences":{"DrugCentral":["5191"]},"count":4,"linkedTargets":{"rows":["ENSG00000171105"],"count":1},"linkedDiseases":{"rows":["EFO_0004593","EFO_0002614","EFO_0001359","EFO_0001645","HP_0003074","EFO_0003884","HP_0011015","EFO_1000897","EFO_0001360","EFO_0000400","EFO_0005672","EFO_0000311"],"count":12},"description":"Protein drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1966 and has 4 investigational indications."}
{"id":"CHEMBL1201645","drugType":"Unknown","blackBoxWarning":false,"name":"INTRINSIC FACTOR","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Castle's intrinsic factor","Intrinsic factor"],"count":1,"approvedIndications":["EFO_0004272"],"description":"Unknown drug with a maximum clinical trial phase of IV and is indicated for anemia (phenotype)."}
{"id":"CHEMBL1201782","canonicalSmiles":"CNC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.CNC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.C[C@@H](O[C@H]1OCCN(Cc2nn(P(=O)(O)O)c(=O)[nH]2)[C@H]1c1ccc(F)cc1)c1cc(C(F)(F)F)cc(C(F)(F)F)c1","inchiKey":"VRQHBYGYXDWZDL-OOZCZQCLSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FOSAPREPITANT DIMEGLUMINE","yearOfFirstApproval":2008,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1199324","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Emend","Fosaprepitant dimeglumine"],"synonyms":["Fosaprepitant dimeglumine","Fosaprepitant meglumine","MK-0517"],"crossReferences":{"DailyMed":["fosaprepitant%20dimeglumine"],"chEBI":["64311"]},"count":3,"approvedIndications":["EFO_0006911","EFO_0004888"],"linkedTargets":{"rows":["ENSG00000115353"],"count":1},"linkedDiseases":{"rows":["EFO_0006911","EFO_0004888","EFO_0000691"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2008 and is indicated for post operative nausea and vomiting and chemotherapy-induced nausea and vomiting and has 1 investigational indication."}
{"id":"CHEMBL1208642","canonicalSmiles":"O=S(=O)(O)S","inchiKey":"DHCDFWKWKRSZHF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"THIOSULFURIC ACID","yearOfFirstApproval":1992,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Thiosulfate"],"crossReferences":{"DailyMed":["sodium%20thiosulfate"],"drugbank":["DB09499"],"chEBI":["29279"]},"childChemblIds":["CHEMBL3753202","CHEMBL2251960","CHEMBL2096650"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1992."}
{"id":"CHEMBL1213460","canonicalSmiles":"CCOC(=O)C1N=C(c2ccccc2F)c2cc(Cl)ccc2NC1=O","inchiKey":"CUCHJCMWNFEYOM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ETHYL LOFLAZEPATE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Ethyl loflazepate"],"crossReferences":{"Wikipedia":["Ethyl_loflazepate"],"drugbank":["DB01545"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL1230575","canonicalSmiles":"CC(C)=CCC/C(C)=C/CC/C(C)=C/CC/C(C)=C/CC/C(C)=C/CC/C(C)=C/CC/C(C)=C/CC1=C(C)C(=O)c2ccccc2C1=O","inchiKey":"RAKQPZMEYJZGPI-LJWNYQGCSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MENAQUINONE 7","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Menaquinone 7","Menaquinone-7"],"crossReferences":{"drugbank":["DB13075"],"chEBI":["44245"]},"description":"Small molecule drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL1232702","canonicalSmiles":"COC(=O)C1CCN(C(=O)c2ccc(N(C)Cc3cnc4nc(N)nc(N)c4n3)cc2)CC1","inchiKey":"UKCFUFHREWUXJJ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1232702","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07765"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1234619","canonicalSmiles":"N[C@@H](Cc1ccc2ccccc2c1)C(=O)O","inchiKey":"JPZXHKDZASGCLU-LBPRGKRZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1234619","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB01766"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1235556","canonicalSmiles":"O=C(O)Cn1cc(Cc2nc3c(F)c(F)cc(F)c3s2)c2cccnc21","inchiKey":"IEVFQDJUDLCOQY-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1235556","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08449"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1235647","canonicalSmiles":"O=C(O)CCCC[C@@H](S)CCS","inchiKey":"IZFHEQBZOYJLPK-SSDOTTSWSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DIHYDROLIPOIC ACID","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["6,8-Dimercaptooctanoic Acid","Dihydrolipoic Acid","Dihydrolipoicacid"],"crossReferences":{"drugbank":["DB03760"],"chEBI":["45230"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1235738","canonicalSmiles":"C#CCN[C@H]1CCc2ccccc21","inchiKey":"RUOKEQAAGRXIBM-LBPRGKRZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AZILECT","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB03894"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1236475","canonicalSmiles":"O=C1N[C@H](O)CCN1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O","inchiKey":"UCKYOOZPSJFJIZ-FMDGEEDCSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TETRAHYDROURIDINE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["NSC-112907","NSC-112907-D","Tetrahydrouridine","U-23284"],"count":8,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 8 investigational indications."}
{"id":"CHEMBL1237044","canonicalSmiles":"COc1cccc(C2(O)CCCCC2CN(C)C)c1","inchiKey":"TVYLLZQTGLZFBW-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"TRAMADOL","yearOfFirstApproval":1995,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["ETS-6103","ETS6103","Tramadol","Ultracet","Ultram"],"crossReferences":{"DailyMed":["tramadol%20hydrochloride"],"chEBI":["75722"]},"childChemblIds":["CHEMBL1237065"],"count":16,"approvedIndications":["EFO_0003843"],"linkedTargets":{"rows":["ENSG00000112038"],"count":1},"linkedDiseases":{"rows":["EFO_1001139","EFO_0005687","MONDO_0002009","MONDO_0007254","EFO_0003964","EFO_1000783","EFO_0002506","HP_0030834","EFO_0004253","EFO_0009093","EFO_0004616","EFO_1000652","HP_0003419","EFO_0003877","EFO_1001250","EFO_0005762","EFO_0000685","EFO_0004210","HP_0012532","EFO_0010072","EFO_0003898","EFO_0001358","HP_0003418","EFO_0003843","EFO_0000311","EFO_0000546","EFO_0005800","EFO_1000391","HP_0030833","HP_0100607","EFO_0003766","EFO_0005611","EFO_0003833","HP_0000023"],"count":34},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1995 and is indicated for pain and has 15 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1237099","canonicalSmiles":"COc1cc(CC2c3c(cc(OC)c(OC)c3OC)CC[N+]2(C)CCCOC(=O)CCC(=O)OCCC[N+]2(C)CCc3cc(OC)c(OC)c(OC)c3C2Cc2cc(OC)c(OC)c(OC)c2)cc(OC)c1OC.[Cl-].[Cl-]","inchiKey":"APADFLLAXHIMFU-UHFFFAOYSA-L","drugType":"Small molecule","blackBoxWarning":false,"name":"DOXACURIUM CHLORIDE","yearOfFirstApproval":1991,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1237123","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Nuromax"],"synonyms":["BW A938U DICHLORIDE","BW-A938U","Doxacurium chloride"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1991."}
{"id":"CHEMBL1245","canonicalSmiles":"CC1(C)C2CCC1(CS(=O)(=O)[O-])C(=O)C2.O=C1N(Cc2ccccc2)C2C[S+]3CCCC3C2N1Cc1ccccc1","inchiKey":"HALWUDBBYKMYPW-UHFFFAOYSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"TRIMETHAPHAN CAMSYLATE","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1201329","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Arfonad"],"synonyms":["Trimetaphan camsilate","Trimetaphan camsylate","Trimethaphan Camsylate","Trimethaphan camphorsulfonate","Trimethaphan camsylate"],"crossReferences":{"Wikipedia":["Trimetaphan_camsilate"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1982."}
{"id":"CHEMBL1257040","canonicalSmiles":"CN1CCN(CCCN2c3ccccc3Sc3ccc(C(F)(F)F)cc32)CC1.Cl.Cl","inchiKey":"BXDAOUXDMHXPDI-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"TRIFLUOPERAZINE HYDROCHLORIDE","yearOfFirstApproval":1959,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL422","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Stelazine","Trifluoperazine hydrochloride"],"synonyms":["Trifluoperazine Dihydrochloride","Trifluoperazine HCl","Trifluoperazine hydrochloride","Trifluoperazine maleate"],"crossReferences":{"DailyMed":["trifluoperazine%20hydrochloride"],"PubChem":["144203568","170465265","26747694","26747695","50107169"],"chEBI":["9710"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1959. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1257051","canonicalSmiles":"Cn1nnc(-c2ccc(-c3ccc(N4C[C@H](CO)OC4=O)cc3F)cn2)n1","inchiKey":"XFALPSLJIHVRKE-GFCCVEGCSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TEDIZOLID","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Sivextro"],"synonyms":["TR-700","Tedizolid","Torezolid"],"crossReferences":{"Wikipedia":["Torezolid"],"drugbank":["DB14569"],"chEBI":["82717"]},"count":2,"approvedIndications":["EFO_0000771"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and is indicated for bacterial disease and has 1 investigational indication."}
{"id":"CHEMBL126589","canonicalSmiles":"Nc1nc2cc(O)ccc2[nH]1","inchiKey":"FNSYWIPPPFVBAV-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL126589","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB03729"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1267","canonicalSmiles":"CC(O)c1ccc(CCOc2ccc(CC3SC(=O)NC3=O)cc2)nc1","inchiKey":"OXVFDZYQLGRLCD-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LERIGLITAZONE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Leriglitazone","MIN-102","Min-102"],"crossReferences":{"drugbank":["DB15021"],"chEBI":["82937"]},"childChemblIds":["CHEMBL4298170"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL1276416","canonicalSmiles":"C[C@@H](O)[C@H]1C(=O)N2[C@@H]1[C@@H](C)C(S[C@@H]1CN[C@H](CNS(N)(=O)=O)C1)=[14C]2C(=O)O","inchiKey":"AVAACINZEOAHHE-YZCBYFCHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"[14C]-DORIPENEM","maximumClinicalTrialPhase":0,"parentId":"CHEMBL491571","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Doripenem"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1287853","canonicalSmiles":"Cc1cnc(Nc2ccc(OCCN3CCCC3)cc2)nc1Nc1cccc(S(=O)(=O)NC(C)(C)C)c1","inchiKey":"JOOXLOJCABQBSG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FEDRATINIB","yearOfFirstApproval":2019,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Fedratinib","SAR-302503","SAR302503","Sar-302503","TG-101348","TG101348"],"crossReferences":{"DailyMed":["fedratinib%20hydrochloride"],"drugbank":["DB12500"]},"childChemblIds":["CHEMBL4297216"],"count":6,"approvedIndications":["EFO_0000616"],"linkedTargets":{"rows":["ENSG00000096968","ENSG00000122025"],"count":2},"linkedDiseases":{"rows":["EFO_0002430","EFO_0000616","EFO_0003086","MONDO_0044903","EFO_0001421","EFO_0002429"],"count":6},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2019 and is indicated for neoplasm and has 5 investigational indications."}
{"id":"CHEMBL1324714","canonicalSmiles":"CN1CCN(C(c2ccccc2)c2ccccc2)CC1.Cl","inchiKey":"UKPBEPCQTDRZSE-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CYCLIZINE HYDROCHLORIDE","maximumClinicalTrialPhase":4,"parentId":"CHEMBL648","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Marzine"],"synonyms":["Cyclizine hydrochloride"],"crossReferences":{"PubChem":["56463235"],"chEBI":["51045"]},"description":"Small molecule drug with a maximum clinical trial phase of IV."}
{"id":"CHEMBL1370561","canonicalSmiles":"Cn1c(=O)c2[nH]cnc2n(C)c1=O.Cn1c(=O)c2[nH]cnc2n(C)c1=O.NCCN","inchiKey":"FQPFAHBPWDRTLU-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AMINOPHYLLINE","yearOfFirstApproval":1940,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL190","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Aminophyllin","Aminophylline","Aminophylline In Sodium Chloride","Aminophylline dye free","Ammophyllin","Amnivent-225 sr","Amnivent-350 sr","Peterphyllin","Phyllocontin","Somophyllin","Somophyllin-df","Truphylline"],"synonyms":["Aminophylline","NSC-7919","Theophyllamine","Theophylline ethylenediamine"],"crossReferences":{"DailyMed":["aminophylline"],"PubChem":["11111990","11111991","50105733","85231291"],"drugbank":["DB01223"]},"count":9,"approvedIndications":["HP_0006536","EFO_0000270"],"linkedTargets":{"rows":["ENSG00000152270","ENSG00000282608","ENSG00000065989","ENSG00000170425","ENSG00000105650","ENSG00000163485","ENSG00000128271","ENSG00000113448","ENSG00000172572","ENSG00000184588"],"count":10},"linkedDiseases":{"rows":["HP_0006536","EFO_0001361","HP_0001919","EFO_0000270","EFO_0003884","EFO_1000782","EFO_0003917","HP_0002315","EFO_0009492","MONDO_0001187"],"count":10},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1940 and is indicated for asthma and airway obstruction and has 7 investigational indications."}
{"id":"CHEMBL1481","canonicalSmiles":"CCC1=C(C)CN(C(=O)NCCc2ccc(S(=O)(=O)NC(=O)N[C@H]3CC[C@H](C)CC3)cc2)C1=O","inchiKey":"WIGIZIANZCJQQY-RUCARUNLSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GLIMEPIRIDE","yearOfFirstApproval":1995,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Amaryl","Glimepiride","Niddaryl"],"synonyms":["Amaryl","Glimepiride","HOE 490","HOE-490"],"crossReferences":{"DailyMed":["glimepiride"],"PubChem":["144204264","170464966","49648856"],"Wikipedia":["Glimepiride"],"drugbank":["DB00222"],"chEBI":["5383"]},"count":6,"approvedIndications":["Orphanet_552","EFO_0001360","EFO_0000400"],"linkedTargets":{"rows":["ENSG00000187486","ENSG00000006071"],"count":2},"linkedDiseases":{"rows":["EFO_0003914","HP_0003124","EFO_0003095","Orphanet_552","EFO_0001645","EFO_0001360","EFO_0000400","HP_0012594","EFO_0000537"],"count":9},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1995 and has 3 approved and 3 investigational indications."}
{"id":"CHEMBL1483877","canonicalSmiles":"CCOc1ccccc1C(N)=O","inchiKey":"SBNKFTQSBPKMBZ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ETHENZAMIDE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Etenzamide","Ethenzamide"],"crossReferences":{"PubChem":["144204707","144207223","170465775","17389894","87334323"],"drugbank":["DB13544"]},"count":2,"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL1519829","canonicalSmiles":"CN(C)CCOC(c1ccc(Cl)cc1)c1ccccn1.O=C(O)/C=C/C(=O)O","inchiKey":"GVNWHCVWDRNXAZ-WLHGVMLRSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1519829","maximumClinicalTrialPhase":0,"parentId":"CHEMBL864","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["11532951"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1540","canonicalSmiles":"Nc1nc(O)c2ncn(CCC(CO)CO)c2n1","inchiKey":"JNTOCHDNEULJHD-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PENCICLOVIR","yearOfFirstApproval":1996,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Denavir","Fenistil","Vectavir"],"synonyms":["BRL-39123","Penciclovir"],"crossReferences":{"DailyMed":["penciclovir"],"PubChem":["144205801","170464955"],"Wikipedia":["Penciclovir"],"drugbank":["DB00299"],"chEBI":["7956"]},"childChemblIds":["CHEMBL2079793"],"count":2,"approvedIndications":["EFO_1001347","EFO_0000763"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1996 and is indicated for herpes labialis and viral disease."}
{"id":"CHEMBL167731","canonicalSmiles":"NCCNc1ccc(NCCN)c2c1C(=O)c1ccncc1C2=O","inchiKey":"PEZPMAYDXJQYRV-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PIXANTRONE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["BBR 2778","BBR-2778","Pixantrone"],"crossReferences":{"PubChem":["225144373"],"Wikipedia":["Pixantrone"],"drugbank":["DB06193"]},"childChemblIds":["CHEMBL537394","CHEMBL2103844"],"count":7,"approvedIndications":["EFO_0000616"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and is indicated for neoplasm and has 6 investigational indications."}
{"id":"CHEMBL1702228","canonicalSmiles":"CCOC(=O)c1cccc(N)c1","inchiKey":"ZMCBYSBVJIMENC-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1702228","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["29217778"],"drugbank":["DB11552"],"chEBI":["81494"]},"childChemblIds":["CHEMBL3184210"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1710321","canonicalSmiles":"CCCCCCCCCCCCCCCC[n+]1ccccc1.O.[Br-]","inchiKey":"HVWZDJSNXREVCK-UHFFFAOYSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1710321","maximumClinicalTrialPhase":0,"parentId":"CHEMBL305906","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["93576767"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1742988","drugType":"Protein","blackBoxWarning":false,"name":"BAMINERCEPT","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BG 9924","BG-9924","BG9924","Baminercept","TT-47"],"count":4,"linkedTargets":{"rows":["ENSG00000226979","ENSG00000125735","ENSG00000227507"],"count":3},"linkedDiseases":{"rows":["EFO_0000685","EFO_0004220","EFO_0008522","EFO_0000699"],"count":4},"description":"Protein drug with a maximum clinical trial phase of II (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL1743018","drugType":"Antibody","blackBoxWarning":false,"name":"FICLATUZUMAB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AV 299","AV-299","Ficlatuzumab","SCH 900105","SCH-900105"],"count":7,"linkedTargets":{"rows":["ENSG00000019991"],"count":1},"linkedDiseases":{"rows":["EFO_0002618","EFO_0000222","EFO_0001378","EFO_0000707","EFO_0000181","EFO_0003060","EFO_0000519"],"count":7},"description":"Antibody drug with a maximum clinical trial phase of II (across all indications) and has 7 investigational indications."}
{"id":"CHEMBL1743258","canonicalSmiles":"CN1C[C@H](C(=O)N[C@]2(C)O[C@@]3(O)[C@@H]4CCCN4C(=O)[C@H](Cc4ccccc4)N3C2=O)C=C2c3cccc4[nH]cc(c34)C[C@H]21.CN1C[C@H](C(=O)N[C@]2(C)O[C@@]3(O)[C@@H]4CCCN4C(=O)[C@H](Cc4ccccc4)N3C2=O)C=C2c3cccc4[nH]cc(c34)C[C@H]21","inchiKey":"LRSFWJKFODHITK-CEFVCFRBSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DIERGOTAMINE","maximumClinicalTrialPhase":0,"parentId":"CHEMBL442","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Diergotamine"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL174391","canonicalSmiles":"C1CCN(C2CCNCC2)CC1","inchiKey":"QDVBKXJMLILLLB-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"[1,4']Bipiperidinyl","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["[1,4']Bipiperidinyl"],"crossReferences":{"drugbank":["DB03056"],"chEBI":["40117"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1760433","canonicalSmiles":"CNC(=O)c1cc(Oc2ccc(N[11C](=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1","inchiKey":"MLDQJTXFUGDVEO-LRFGSCOBSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"[11C]-SORAFENIB","maximumClinicalTrialPhase":0,"parentId":"CHEMBL1336","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["[11C]-Sorafenib"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1774461","canonicalSmiles":"CNc1ccc(/C=C/c2ccc(OCCOCCOCC[18F])nc2)cc1","inchiKey":"YNDIAUKFXKEXSV-CRYLGTRXSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FLORBETAPIR F 18","yearOfFirstApproval":2012,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1908919","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Amyvid"],"synonyms":["(18F)AV-45","18F-AV-45","AV-45 F-18","Florbetapir (18f)","Florbetapir f 18","Florbetapir f-18"],"crossReferences":{"DailyMed":["florbetapir%20f-18"],"drugbank":["DB09149"],"chEBI":["66880"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 2012 and has 1 investigational indication."}
{"id":"CHEMBL184041","canonicalSmiles":"Cc1cc(-c2c3ccccc3c(Br)c3sc(C)c(C)c23)cc(C)c1O[C@H](Cc1ccccc1)C(=O)O","inchiKey":"FONCZICQWCUXEB-RUZDIDTESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ERTIPROTAFIB","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Ertiprotafib","PTP-112"],"crossReferences":{"drugbank":["DB06521"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL18442","canonicalSmiles":"c1cc(CN2CCCNCCNCCCNCC2)ccc1CN1CCCNCCNCCCNCC1","inchiKey":"YIQPUIGJQJDJOS-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PLERIXAFOR","yearOfFirstApproval":2008,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Mozobil"],"synonyms":["AMD3100","Plerixafor"],"crossReferences":{"DailyMed":["plerixafor"],"PubChem":["174007494","29217477"],"Wikipedia":["Plerixafor"],"drugbank":["DB06809"]},"childChemblIds":["CHEMBL1788331","CHEMBL2311028","CHEMBL2088494","CHEMBL2373140","CHEMBL2311089"],"count":31,"approvedIndications":["EFO_0000220","EFO_0001378","EFO_0005952"],"linkedTargets":{"rows":["ENSG00000121966"],"count":1},"linkedDiseases":{"rows":["Orphanet_84","EFO_0003086","Orphanet_232","MONDO_0003783","EFO_1001465","EFO_1001469","EFO_0005952","EFO_1001311","EFO_0000565","MONDO_0015760","EFO_1001459","MONDO_0001475","EFO_1001996","EFO_0000183","EFO_0000400","EFO_0000717","Orphanet_379","EFO_0000198","EFO_0002618","EFO_0006859","EFO_0000220","MONDO_0019457","EFO_0000403","EFO_0000222","MONDO_0000870","MONDO_0044881","EFO_0004599","EFO_1000654","EFO_0000095","EFO_0001359","EFO_0000574","EFO_0001378","MONDO_0018906","EFO_0000691"],"count":34},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2008 and has 3 approved and 28 investigational indications."}
{"id":"CHEMBL1901620","canonicalSmiles":"CCCCC[C@H](O)/C=C/C1=C(C/C=C\\CCCC(=O)O)C(=O)CC1","inchiKey":"PRFXRIUZNKLRHM-HKVRTXJWSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1901620","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["26754807"],"drugbank":["DB02304"],"chEBI":["28099"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL191886","canonicalSmiles":"Cc1ncc2c(c1O)COC2c1ccc(Cl)cc1","inchiKey":"CVKNDPRBJVBDSS-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CICLETANINE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["(+/-)BN-1270","BN-1270","Cicletanine","WIN 90,000","WIN-90000"],"crossReferences":{"Wikipedia":["Cicletanine"],"drugbank":["DB12766"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL194378","canonicalSmiles":"CN(C)CCc1c[nH]c2cccc(OP(=O)(O)O)c12","inchiKey":"QVDSEJDULKLHCG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PSILOCYBINE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CY 39","CY-39","Psilocybin","Psilocybine"],"crossReferences":{"PubChem":["144206451"],"Wikipedia":["Psilocybin"],"drugbank":["DB11664"],"chEBI":["8614"]},"count":11,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 11 investigational indications."}
{"id":"CHEMBL1963681","canonicalSmiles":"COc1ccc(C/N=c2\\[nH]c(N3CCC[C@H]3CO)ncc2C(=O)NCc2ncccn2)cc1Cl","inchiKey":"WEAJZXNPAWBCOA-INIZCTEOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AVANAFIL","yearOfFirstApproval":2011,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Spedra","Stendra"],"synonyms":["Avanafil","TA-1790"],"crossReferences":{"DailyMed":["avanafil"],"PubChem":["165222624"],"Wikipedia":["Avanafil"],"drugbank":["DB06237"],"chEBI":["66876"]},"count":2,"approvedIndications":["EFO_0004234"],"linkedTargets":{"rows":["ENSG00000138735"],"count":1},"linkedDiseases":{"rows":["EFO_0003086","EFO_0004234"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2011 and is indicated for erectile dysfunction and has 1 investigational indication."}
{"id":"CHEMBL1981292","canonicalSmiles":"CC(C)CC(NC(=O)CNC(=O)C(Cc1ccc(O)cc1)NC(=O)C(CO)NC(=O)C(Cc1c[nH]c2ccccc12)NC(=O)C(Cc1c[nH]cn1)NC(=O)C1CCC(=O)N1)C(=O)NC(CCCNC(=N)N)C(=O)N1CCCC1C(=O)NCC(N)=O","inchiKey":"XLXSAKCOAKORKW-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1981292","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["124893762"],"drugbank":["DB00644"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1983570","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1983570","maximumClinicalTrialPhase":0,"parentId":"CHEMBL414804","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["569872"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2028661","canonicalSmiles":"CCOc1nc2cccc(C(=O)OCc3oc(=O)oc3C)c2n1Cc1ccc(-c2ccccc2-c2noc(=O)[nH]2)cc1","inchiKey":"QJFSABGVXDWMIW-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"AZILSARTAN MEDOXOMIL","yearOfFirstApproval":2011,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Edarbi"],"synonyms":["AR-14","Azilsartan medoxomil","TAK 491","TAK-491"],"crossReferences":{"DailyMed":["azilsartan%20kamedoxomil"],"drugbank":["DB08822"],"chEBI":["68845"]},"childChemblIds":["CHEMBL2103795"],"count":3,"approvedIndications":["EFO_0000319"],"linkedTargets":{"rows":["ENSG00000144891"],"count":1},"linkedDiseases":{"rows":["EFO_1002032","EFO_0000319","EFO_0000537"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2011 and is indicated for cardiovascular disease and has 2 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL2047159","canonicalSmiles":"Cc1cc(OCCCS(C)(=O)=O)cc(C)c1-c1cccc(COc2ccc3c(c2)OC[C@H]3CC(=O)O)c1.O","inchiKey":"FOFXXEHXOCAJIW-GNAFDRTKSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TAK-875","maximumClinicalTrialPhase":0,"parentId":"CHEMBL1829174","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["TAK-875"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2063078","canonicalSmiles":"C=C[C@@H]1C[C@]1(NC(=O)[C@@H]1C[C@@H]2CN1C(=O)[C@H](C(C)(C)C)NC(=O)O[C@@H]1C[C@H]1CCCCCc1nc3ccc(OC)cc3nc1O2)C(=O)[N-]S(=O)(=O)C1CC1.[K+]","inchiKey":"MVOGOEKATQJYHW-CIAYNJNFSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL2063078","maximumClinicalTrialPhase":0,"parentId":"CHEMBL2063090","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2068726","canonicalSmiles":"C/C(=C\\C(=O)OCCCCCCCCC(=O)[O-])C[C@@H]1OC[C@H](C[C@@H]2O[C@H]2[C@@H](C)[C@H](C)O)[C@@H](O)[C@H]1O.C/C(=C\\C(=O)OCCCCCCCCC(=O)[O-])C[C@@H]1OC[C@H](C[C@@H]2O[C@H]2[C@@H](C)[C@H](C)O)[C@@H](O)[C@H]1O.[Ca+2]","inchiKey":"HAXVBVDETFUQGV-LNQHITRNSA-L","drugType":"Small molecule","blackBoxWarning":false,"name":"MUPIROCIN CALCIUM","maximumClinicalTrialPhase":0,"parentId":"CHEMBL719","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Bactroban","Mupirocin"],"synonyms":["BRL-4910F"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2079130","canonicalSmiles":"CNCc1cc(-c2ccccc2F)n(S(=O)(=O)c2cccnc2)c1","inchiKey":"BFDBKMOZYNOTPK-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"VONOPRAZAN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Takecab","Vocinti"],"synonyms":["TAK-438","Vonoprazan"],"crossReferences":{"drugbank":["DB11739"]},"childChemblIds":["CHEMBL2064032"],"count":3,"linkedTargets":{"rows":["ENSG00000105675","ENSG00000186009"],"count":2},"linkedDiseases":{"rows":["EFO_0003948","HP_0004398","EFO_0009454","EFO_0004607","EFO_1000961","EFO_1001095"],"count":6},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL2087361","canonicalSmiles":"C#Cc1cccc(Nc2ncnc3cc4c(cc23)OCCOCCOCCO4)c1","inchiKey":"QQLKULDARVNMAL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ICOTINIB","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BPI-2009H","Icotinib"],"crossReferences":{"drugbank":["DB11737"]},"childChemblIds":["CHEMBL4297665"],"count":13,"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 13 investigational indications."}
{"id":"CHEMBL2103738","canonicalSmiles":"O.O.O.O.O=C([O-])CC(O)(CC(=O)[O-])C(=O)[O-].[Li+].[Li+].[Li+]","inchiKey":"HXGWMCJZLNWEBC-UHFFFAOYSA-K","drugType":"Small molecule","blackBoxWarning":true,"name":"LITHIUM CITRATE","yearOfFirstApproval":1980,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1201170","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Li-liquid","Litarex","Lithium citrate","Lithonate"],"synonyms":["Lithium citrate"],"crossReferences":{"DrugCentral":["4512"],"chEBI":["64754"]},"count":1,"approvedIndications":["EFO_0005407"],"linkedTargets":{"rows":["ENSG00000082701","ENSG00000105723","ENSG00000133731"],"count":3},"linkedDiseases":{"rows":["EFO_0005407"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1980 and is indicated for psychosis. This drug has a black box warning from the FDA."}
{"id":"CHEMBL2104402","canonicalSmiles":"CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H]1CCCCCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1)C(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](C)C(=O)NCC(=O)N[C@H](C(=O)N1CCC[C@H]1C(N)=O)[C@@H](C)O)C(C)C)[C@@H](C)O)[C@@H](C)O","inchiKey":"DDPFHDCZUJFNAT-PZPWKVFESA-N","drugType":"Protein","blackBoxWarning":false,"name":"ELCATONIN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Elcatonin"],"count":1,"description":"Protein drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2104700","canonicalSmiles":"Cc1ccc(C2(O)CCN(CCCC(=O)c3ccc(F)cc3)CC2)cc1","inchiKey":"AGAHNABIDCTLHW-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MOPERONE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Methylperidol","Moperone","Moperone hydrochloride","R 1658"],"crossReferences":{"drugbank":["DB13554"]},"childChemblIds":["CHEMBL2357018"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2104753","canonicalSmiles":"COc1ccc2nc(COc3ccc(CC4SC(=O)NC4=O)cc3)n(C)c2c1","inchiKey":"XMSXOLDPMGMWTH-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"RIVOGLITAZONE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CS-011","DE-101","R 106056","R-106056","Rivoglitazone"],"crossReferences":{"drugbank":["DB09200"]},"childChemblIds":["CHEMBL3526906","CHEMBL3527103","CHEMBL3526905"],"count":2,"linkedTargets":{"rows":["ENSG00000132170"],"count":1},"linkedDiseases":{"rows":["EFO_1000906","EFO_0001360"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2104973","canonicalSmiles":"COc1ccc2c(c1)N(C[C@H](C)CN(C)C)c1ccccc1S2.Cl","inchiKey":"ODLGFPIWRAEFAN-PFEQFJNWSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LEVOMEPROMAZINE HYDROCHLORIDE","maximumClinicalTrialPhase":4,"parentId":"CHEMBL1764","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Nozinan"],"synonyms":["Levomepromazine hydrochloride"],"description":"Small molecule drug with a maximum clinical trial phase of IV."}
{"id":"CHEMBL2105399","canonicalSmiles":"Cc1nc(NS(=O)(=O)c2ccc(N)cc2)oc1C","inchiKey":"CYFLXLSBHQBMFT-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SULFAMOXOLE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Sulfamoxole","Sulphamoxole"],"crossReferences":{"drugbank":["DB08798"],"chEBI":["55548"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2105740","canonicalSmiles":"Cc1cc2c(cc1CC(=O)c1sccc1S(=O)(=O)[N-]c1onc(C)c1Cl)OCO2.[Na+]","inchiKey":"MDTNUYUCUYPIHE-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SITAXENTAN SODIUM","yearOfFirstApproval":2006,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL282724","hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["European Union"],"classes":["Hepatotoxicity"],"year":2010},"tradeNames":["Thelin"],"synonyms":["Sitaxentan sodium","Sitaxsentan sodium","Sitaxsentan sodium salt","TBC-11251 SODIUM","TBC-11251NA","TBC-11251Z"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 2006. It was withdrawn in European Union  in 2010 due to Hepatotoxicity."}
{"id":"CHEMBL2106236","canonicalSmiles":"COc1ccc2c(c1)CC[C@@H]1[C@@H]2CC[C@]2(C)[C@H](O)[C@H](O)C[C@@H]12","inchiKey":"UHQGCIIQUZBJAE-RRQVMCLOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"EPIMESTROL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Epimestrol","ORG 817"],"crossReferences":{"drugbank":["DB13386"],"chEBI":["34738"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2106483","canonicalSmiles":"CCOc1ccccc1OCC1CNCCO1.Cl","inchiKey":"HJOCKFVCMLCPTP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"VILOXAZINE HYDROCHLORIDE","maximumClinicalTrialPhase":4,"parentId":"CHEMBL306700","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Vivalan"],"synonyms":["ICI 58,834","ICI-58834","SPN-812","Spn-812","Viloxazine hydrochloride"],"crossReferences":{"PubChem":["170466300"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of IV and has 1 investigational indication."}
{"id":"CHEMBL2106822","canonicalSmiles":"CCN(CC)Cc1nccn1-c1ccc([N+](=O)[O-])cc1C(=O)c1ccccc1Cl","inchiKey":"WZGBZLHGOVJDET-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NIZOFENONE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Nizofenone","Nizofenone fumarate"],"crossReferences":{"PubChem":["144206537","170466022"],"drugbank":["DB13546"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2106840","canonicalSmiles":"CCCOCCOC(=O)C1=C(C)NC(C)=C(C(=O)OCCOCCC)C1c1cccc([N+](=O)[O-])c1","inchiKey":"VZWXXKDFACOXNT-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NILUDIPINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Niludipine"],"crossReferences":{"drugbank":["DB09240"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2107357","canonicalSmiles":"CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21.O=P(O)(O)O.O=P(O)(O)O","inchiKey":"ONDPWWDPQDCQNJ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MOTESANIB DIPHOSPHATE","maximumClinicalTrialPhase":3,"parentId":"CHEMBL572881","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AMG 706","Motesanib diphosphate","Motesanib phosphate"],"count":17,"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 17 investigational indications."}
{"id":"CHEMBL2108228","drugType":"Antibody","blackBoxWarning":false,"name":"BECTUMOMAB","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Lympho scan","Lymphoscan"],"synonyms":["Bectumomab","IMMU-LL2","Technetium tc 99m bectumomab"],"description":"Antibody drug with a maximum clinical trial phase of III."}
{"id":"CHEMBL2108401","drugType":"Antibody","blackBoxWarning":false,"name":"ENLIMOMAB PEGOL","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BIRR-1","Enlimomab pegol","R6.5"],"description":"Antibody drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL2108621","drugType":"Antibody","blackBoxWarning":false,"name":"MAPATUMUMAB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["HGS-1012","HGS-ETR1","HGS1012","Mapatumumab","TRAIL-R 1MAB","TRAIL-R1 MAB","TRM-1","TRM-1 HGS-ETR1"],"count":5,"linkedTargets":{"rows":["ENSG00000104689"],"count":1},"linkedDiseases":{"rows":["MONDO_0002974","EFO_0000182","EFO_0001378","EFO_0005952","EFO_0003060"],"count":5},"description":"Antibody drug with a maximum clinical trial phase of II (across all indications) and has 5 investigational indications."}
{"id":"CHEMBL2109283","drugType":"Antibody","blackBoxWarning":false,"name":"BICIROMAB BRALLOBARBITAL","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Fibriscint"],"synonyms":["Biciromab brallobarbital","T2G1S"],"description":"Antibody drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2109309","drugType":"Antibody","blackBoxWarning":false,"name":"RHIGM12B7","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["RHIGM12B7","Rhigm12b7"],"count":1,"linkedTargets":{"rows":["ENSG00000197646"],"count":1},"linkedDiseases":{"rows":["EFO_0000389"],"count":1},"description":"Antibody drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2109496","drugType":"Antibody","blackBoxWarning":false,"name":"MLN-01","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["MLN-01"],"description":"Antibody drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2109606","drugType":"Antibody","blackBoxWarning":false,"name":"GSK-1070806","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["GSK-1070806","Gsk-1070806"],"count":4,"linkedTargets":{"rows":["ENSG00000150782"],"count":1},"linkedDiseases":{"rows":["EFO_0003780","EFO_0000400","EFO_0000384","EFO_0003767"],"count":4},"description":"Antibody drug with a maximum clinical trial phase of II (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL2109624","drugType":"Antibody","blackBoxWarning":false,"name":"CAPLACIZUMAB","yearOfFirstApproval":2019,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Cablivi"],"synonyms":["ALX-0081","Caplacizumab","Caplacizumab-yhdp"],"crossReferences":{"DailyMed":["caplacizumab-yhdp"]},"count":2,"approvedIndications":["HP_0004419","MONDO_0019740"],"linkedTargets":{"rows":["ENSG00000110799"],"count":1},"linkedDiseases":{"rows":["HP_0004419","MONDO_0018896","MONDO_0019740"],"count":3},"description":"Antibody drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2019 and is indicated for acquired thrombotic thrombocytopenic purpura and recurrent thrombophlebitis."}
{"id":"CHEMBL2110771","canonicalSmiles":"CC[N+](C)(C)CCC(C(N)=O)(c1ccccc1)c1ccccc1","inchiKey":"KFZMXOLSYABOSE-UHFFFAOYSA-O","drugType":"Small molecule","blackBoxWarning":false,"name":"AMBUTONIUM","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":[],"childChemblIds":["CHEMBL2105972"],"description":"Small molecule drug with a maximum clinical trial phase of IV."}
{"id":"CHEMBL2110948","canonicalSmiles":"C[N+]1(C)CCCC1COC(=O)C(O)(c1ccccc1)c1ccccc1","inchiKey":"CQRKVVAGMJJJSR-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"POLDINE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Poldine"],"crossReferences":{"drugbank":["DB13507"]},"childChemblIds":["CHEMBL2106739"],"count":1,"approvedIndications":["EFO_0010282"],"description":"Small molecule drug with a maximum clinical trial phase of IV and is indicated for gastrointestinal disease."}
{"id":"CHEMBL2111099","canonicalSmiles":"COc1ccc(C(C)(C)C)cc1CN[C@H]1C2CCN(CC2)[C@H]1C(c1ccccc1)c1ccccc1","inchiKey":"OMPCVMLFFSQFIX-CONSDPRKSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MAROPITANT","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Maropitant"],"crossReferences":{"drugbank":["DB11427"]},"childChemblIds":["CHEMBL2107353"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL212616","canonicalSmiles":"CC(C)c1cc(C(C)C)c(S(=O)(=O)N[C@@H](Cc2cccc(C(=N)N)c2)C(=O)N2CCN(C(=O)CCN)CC2)c(C(C)C)c1","inchiKey":"WATXEHGLYJKXOF-NDEPHWFRSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL212616","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB04172"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2151437","canonicalSmiles":"c1cnc2c(c1)C[C@@]1(CN3CCC1CC3)O2","inchiKey":"OCKIPDMKGPYYJS-ZDUSSCGKSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AZD0328","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AZD-0328","AZD0328","Azd 0328","Azd0328"],"crossReferences":{"drugbank":["DB12145"]},"count":2,"linkedTargets":{"rows":["ENSG00000175344"],"count":1},"linkedDiseases":{"rows":["EFO_0000249","EFO_0000692"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2171854","canonicalSmiles":"COc1cc2c(cc1OC)C(=O)[14CH](CC1CCN(Cc3ccccc3)CC1)C2.Cl","inchiKey":"XWAIAVWHZJNZQQ-JUGPOUJBSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"[14C]DONEPEZIL HYDROCHLORIDE","maximumClinicalTrialPhase":0,"parentId":"CHEMBL502","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["[14C]Donepezil HCl"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL221046","canonicalSmiles":"CC(C)C[C@@]1(C(=O)O)C[C@H](C(=O)O)[C@H](c2nccs2)N1C(=O)c1ccc(C(C)(C)C)cc1","inchiKey":"SWYJAQWTBADJTB-RHGYRFJNSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL221046","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07199"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL228369","canonicalSmiles":"CCN(CC)C(=O)c1c(NC(=O)c2cccs2)sc2c1CCCC2","inchiKey":"NZTHBWHANVWSRX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL228369","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08032"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2304327","canonicalSmiles":"CCC(C)CCCCC(=O)N(CS(=O)(=O)O)[C@@H](CCNCS(=O)(=O)O)C(=O)N[C@@H](CN[C@@H](CCNCS(=O)(=O)O)C(=O)N[C@H]1CCNC(=O)[C@H]([C@@H](C)O)NC(=O)[C@@H](CCNCS(=O)(=O)O)NC(=O)[C@H](CCNCS(=O)(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](CCNCS(=O)(=O)O)NC1=O)[C@@H](C)O","inchiKey":"RRDRHWJDBOGQHN-JWCTVYNTSA-N","drugType":"Unknown","blackBoxWarning":false,"name":"COLISTIMETHATE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Colistimethate","Colistin sulfomethate"],"count":1,"description":"Unknown drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL232943","canonicalSmiles":"COC(=O)c1c(Cl)cccc1-c1ccc([C@@H](C)NC(=O)C2(NC(=O)C(F)(F)F)CC2)c(F)c1","inchiKey":"WZZIQHIQMWJNLU-LLVKDONJSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MK0686","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["MK-0686","MK0686","Mk0686"],"crossReferences":{"drugbank":["DB12563"]},"count":2,"linkedTargets":{"rows":["ENSG00000100739"],"count":1},"linkedDiseases":{"rows":["EFO_0002506","EFO_0006510","EFO_0003843"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL236086","canonicalSmiles":"COCc1cc(O)cc2c1O[C@@H](c1ccc(O)cc1)[C@H]1CCC[C@@H]21","inchiKey":"RHQLNMNKTIOREN-AOIWGVFYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL236086","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08020"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2364622","canonicalSmiles":"Cl.NS(=O)(=O)OC[C@@H]1C[C@@H](n2ccc3c(N[C@H]4CCc5ccccc54)ncnc32)C[C@@H]1O","inchiKey":"HJKDNNXKYODZJI-BVMPOVDASA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PEVONEDISTAT HYDROCHLORIDE","maximumClinicalTrialPhase":0,"parentId":"CHEMBL1231160","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["MLN4924-003","Pevonedistat hydrochloride"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2376648","canonicalSmiles":"C[C@@H](Oc1cc(C(=O)Nc2ccc(C(=O)N3CCN(C)CC3)cc2)nnc1N)c1c(Cl)ccc(F)c1Cl","inchiKey":"ONPGOSVDVDPBCY-CQSZACIVSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"X-396","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["X-396"],"crossReferences":{"drugbank":["DB13104"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2401865","canonicalSmiles":"CC[C@H](C)[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCSC)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CO)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)Cc1cnc[nH]1)[C@@H](C)O)[C@@H](C)O)C(C)C)[C@@H](C)O)C(=O)N[C@@H](C)C(=O)O","inchiKey":"PXZWGQLGAKCNKD-DPNMSELWSA-N","drugType":"Protein","blackBoxWarning":false,"name":"OXYNTOMODULIN","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Oxyntomodulin"],"count":2,"description":"Protein drug with a maximum clinical trial phase of I (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL245807","canonicalSmiles":"O=C1Nc2ccccc2C1(c1ccc(O)cc1)c1ccc(O)cc1","inchiKey":"SJDACOMXKWHBOW-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"OXYPHENISATINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Oxyphenisatin","Oxyphenisatine"],"crossReferences":{"PubChem":["144212248","170466393"],"Wikipedia":["Oxyphenisatine"],"drugbank":["DB04823"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL252128","canonicalSmiles":"CCNC(=O)c1cn2ncnc(Nc3cc(C(=O)NOC)ccc3C)c2c1C","inchiKey":"ZZTMFGIGOADCFX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL252128","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB06940"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL255750","canonicalSmiles":"CCc1cc(CCN)ccc1O","inchiKey":"LDAFQVRTSOETPE-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL255750","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07346"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL264702","canonicalSmiles":"O=C(O)c1ccc2c(c1)C(=O)N([C@H](Cc1ccc(O)cc1)C(=O)O)C2=O","inchiKey":"QISJEFYTLZTWIQ-CQSZACIVSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL264702","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["26740843"],"drugbank":["DB07663"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3039506","canonicalSmiles":"Cc1ccc(S(=O)(=O)O)cc1.Cn1c(=O)n(-c2ccc(C(C)(C)C#N)cc2)c2c3cc(-c4cnc5ccccc5c4)ccc3ncc21","inchiKey":"FWURTHAUPVXZHW-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DACTOLISIB TOSYLATE","maximumClinicalTrialPhase":0,"parentId":"CHEMBL1879463","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Dactolisib tosylate","NVP-BEZ235-ANA"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3094198","canonicalSmiles":"CN([11CH3])C(=N)NC(=N)N","inchiKey":"XZWYZXLIPXDOLR-BJUDXGSMSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL3094198","maximumClinicalTrialPhase":0,"parentId":"CHEMBL1431","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3137342","drugType":"Antibody","blackBoxWarning":true,"name":"DINUTUXIMAB","yearOfFirstApproval":2015,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Ch14.18","Dinutuximab","Dinutuximab beta","ch14.18-UTC"],"crossReferences":{"DailyMed":["dinutuximab"],"DrugCentral":["4948"]},"count":5,"approvedIndications":["EFO_0000616","EFO_0000621"],"description":"Antibody drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2015 and is indicated for neoplasm and neuroblastoma and has 3 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL315818","canonicalSmiles":"NCC(CC(=O)O)c1ccccc1","inchiKey":"DAFOCGYVTAOKAJ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PHENIBUT","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Phenibut"],"crossReferences":{"Wikipedia":["Phenibut"],"drugbank":["DB13455"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL316388","canonicalSmiles":"C[C@H]1CN(C(=O)c2ccc(C#N)cc2)[C@H](C)CN1C(=O)[C@@](C)(O)C(F)(F)F","inchiKey":"IWFSHKKFDSWNLZ-BWACUDIHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL316388","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08608"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3181957","canonicalSmiles":"C=CCNc1nc(NCC=C)nc(N2CCN(C(c3ccc(F)cc3)c3ccc(F)cc3)CC2)n1.CS(=O)(=O)O.CS(=O)(=O)O","inchiKey":"MRDBGMJEPGXQHJ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ALMITRINE MESYLATE","maximumClinicalTrialPhase":4,"parentId":"CHEMBL1183717","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Vectarion"],"synonyms":["Almitrine dimesylate","Almitrine mesylate","S-2620"],"crossReferences":{"PubChem":["170466171"],"chEBI":["53779"]},"description":"Small molecule drug with a maximum clinical trial phase of IV."}
{"id":"CHEMBL3182477","canonicalSmiles":"CCOP(=S)(OCC)OP(=S)(OCC)OCC","inchiKey":"XIUROWKZWPIAIB-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SULFOTEP","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["144208954","144213452"],"drugbank":["DB11497"],"chEBI":["38945"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3187503","canonicalSmiles":"CC(C)c1noc(N2CCC(COc3ccc(-c4ccc(S(C)(=O)=O)cc4)nc3)CC2)n1","inchiKey":"AYJRTVVIBJSSKN-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GSK-1292263","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["GSK-1292263","GSK-1292263A","GSK-263A","GSK1292263","Gsk 1292263","Gsk-1292263","Gsk1292263"],"crossReferences":{"PubChem":["174006808"],"drugbank":["DB12627"]},"count":2,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL319467","canonicalSmiles":"NS(=O)(=O)c1ccc(Nc2nc(OCC3CCCCC3)c3nc[nH]c3n2)cc1","inchiKey":"OWXORKPNCHJYOF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NU-6102","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["NU-6102"],"crossReferences":{"drugbank":["DB07126"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL32749","canonicalSmiles":"COc1cc(/C=C/C(=O)O)ccc1O","inchiKey":"KSEBMYQBYZTDHS-HWKANZROSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FERULATE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Ferulic acid"],"crossReferences":{"PubChem":["26748470","47193700","69416"],"Wikipedia":["Ferulic_acid"],"drugbank":["DB07767"],"chEBI":["17620"]},"childChemblIds":["CHEMBL4594451"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL331373","canonicalSmiles":"O=CN(O)CC(=O)O","inchiKey":"URJHVPKUWOUENU-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"HADACIDIN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Hadacidin"],"crossReferences":{"drugbank":["DB02109"],"chEBI":["43040"]},"childChemblIds":["CHEMBL2028418"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3353541","canonicalSmiles":"C[C@]1(C(=O)N(CCCC(=O)O)Cc2cccc(Cl)c2)CCN1C(=O)c1csc2ccccc12","inchiKey":"MPMKMQHJHDHPBE-RUZDIDTESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GLPG-0974","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["GLPG-0974","GLPG0974","Glpg-0974","Glpg0974"],"crossReferences":{"drugbank":["DB15406"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL340032","canonicalSmiles":"CC(C)C[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)CNC(=O)[C@@H](C)NC(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)O","inchiKey":"ZHUJMSMQIPIPTF-IBURTVSXSA-N","drugType":"Protein","blackBoxWarning":false,"name":"DADLE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["DADLE"],"crossReferences":{"drugbank":["DB08856"]},"description":"Protein drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL340978","canonicalSmiles":"CC(C(=O)O)c1ccc2oc(-c3ccc(Cl)cc3)nc2c1","inchiKey":"MITFXPHMIHQXPI-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BENOXAPROFEN","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["United States"," United Kingdom"," United States"," Spain"," Germany"],"classes":["Carcinogenicity"," Dermatological toxicity"," Gastrotoxicity"," Hepatotoxicity"," Nephrotoxicity"],"year":1982},"tradeNames":["Oraflex"],"synonyms":["Benoxaprofen","COMPOUND 90459"],"crossReferences":{"Wikipedia":["Benoxaprofen"],"drugbank":["DB04812"],"chEBI":["76114"]},"count":1,"approvedIndications":["EFO_0005755"],"linkedTargets":{"rows":["ENSG00000108839"],"count":1},"linkedDiseases":{"rows":["EFO_0005755"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1982 and is indicated for rheumatic disease. It was withdrawn in United States,  United Kingdom,  United States,  Spain and  Germany initially in 1982 due to Carcinogenicity,  Dermatological toxicity,  Gastrotoxicity,  Hepatotoxicity and  Nephrotoxicity."}
{"id":"CHEMBL3415305","canonicalSmiles":"Cl.O=C(NCC12CC3CC(CC(C3)C1)C2)c1cc(CCCNCCCO)ccc1Cl","inchiKey":"LZBBHFRRZLDHLE-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL3415305","maximumClinicalTrialPhase":0,"parentId":"CHEMBL3545108","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL352418","canonicalSmiles":"O=C(O)[C@@H]1C[C@@H](O)CN1","inchiKey":"PMMYEEVYMWASQN-DMTCNVIQSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL352418","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["100079"],"drugbank":["DB08847"],"chEBI":["18095"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3545078","drugType":"Small molecule","blackBoxWarning":false,"name":"PF-03814735","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["PF 03814735","PF 3814735","PF-3814735","Pf-03814735"],"count":1,"linkedTargets":{"rows":["ENSG00000087586","ENSG00000178999"],"count":2},"linkedDiseases":{"rows":["EFO_0000616"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL3545146","drugType":"Small molecule","blackBoxWarning":false,"name":"SRX251","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Srx251"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3545225","drugType":"Small molecule","blackBoxWarning":false,"name":"INCB-047986","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Incb-047986","Incb-47986"],"count":4,"linkedTargets":{"rows":["ENSG00000162434"],"count":1},"linkedDiseases":{"rows":["EFO_0000198","EFO_0000685","MONDO_0007254","EFO_0000183"],"count":4},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL3545316","drugType":"Antibody","blackBoxWarning":false,"name":"RINUCUMAB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["REGN-2176","REGN2176","Rinucumab"],"count":1,"linkedTargets":{"rows":["ENSG00000100311"],"count":1},"linkedDiseases":{"rows":["EFO_0001365"],"count":1},"description":"Antibody drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL3545341","canonicalSmiles":"Cl.O=c1[nH]ccc2cc(OC3CCNCC3)ccc12","inchiKey":"KMNVOGVCCZNVNU-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SAR-407899","maximumClinicalTrialPhase":2,"parentId":"CHEMBL1667969","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["SAR-407899","Sar-407899"],"count":2,"linkedTargets":{"rows":["ENSG00000134318","ENSG00000067900"],"count":2},"linkedDiseases":{"rows":["EFO_0004234","EFO_0003884","EFO_0001645"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL3545389","drugType":"Small molecule","blackBoxWarning":false,"name":"LY2245461","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Ly2245461"],"description":"Small molecule drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL3545410","drugType":"Small molecule","blackBoxWarning":false,"name":"TC-6987","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["TC-6987","Tc-6987"],"count":2,"linkedTargets":{"rows":["ENSG00000175344"],"count":1},"linkedDiseases":{"rows":["EFO_0000270","EFO_0001360"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL3707204","canonicalSmiles":"CC[N+](C)(CC)CCOC(c1ccccc1)c1ccccc1.[I-]","inchiKey":"HKOZYKMXXBHEHT-UHFFFAOYSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"(2-BENZHYDRYLOXYETHYL)DIETHYL-METHYLAMMONIUM IODIDE","maximumClinicalTrialPhase":0,"parentId":"CHEMBL3707205","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["(2-benzhydryloxyethyl)diethyl-methylammonium iodide"],"crossReferences":{"drugbank":["DB13769"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL3707228","drugType":"Antibody","blackBoxWarning":false,"name":"PLOZALIZUMAB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["HU-1D9","MLN-1202","MLN1202","Plozalizumab","hu1D9"],"count":5,"linkedTargets":{"rows":["ENSG00000121807"],"count":1},"linkedDiseases":{"rows":["EFO_0003885","EFO_0003914","EFO_0000756","EFO_0000401","EFO_0000319","MONDO_0024880"],"count":6},"description":"Antibody drug with a maximum clinical trial phase of II (across all indications) and has 5 investigational indications."}
{"id":"CHEMBL3707318","drugType":"Small molecule","blackBoxWarning":false,"name":"GRC-17536","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Grc-17536"],"count":1,"linkedTargets":{"rows":["ENSG00000104321"],"count":1},"linkedDiseases":{"rows":["EFO_1000783"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL3911164","canonicalSmiles":"Cc1cccc2c1NC(=O)[C@@H](NC(=O)[C@H](CCC(F)(F)F)[C@H](CCC(F)(F)F)C(N)=O)N=C2c1cccc(F)c1","inchiKey":"SRJNRAQUSAVENA-GSHUGGBRSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BMS-986115","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Bms 986115","Bms-986115"],"crossReferences":{"drugbank":["DB13126"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL398891","canonicalSmiles":"CCOc1ccc(F)c(CCNC(=S)Nc2ccc(Br)cn2)c1Cl","inchiKey":"DTHZUSMREBJMBT-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"THIOUREA, N-(5-BROMO-2-PYRIDINYL)-N'-(2-(2-CHLORO-3-ETHOXY-6-FLUOROPHENYL)ETHYL)-","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["PT-112","Thiourea, n-(5-bromo-2-pyridinyl)-n'-(2-(2-chloro-3-ethoxy-6-fluorophenyl)ethyl)-"],"count":3,"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL3989762","canonicalSmiles":"CC[C@H]1[C@H]2C[C@H]3[C@@H]4N(C)c5ccccc5[C@]45C[C@@H](C2[C@H]5OC(=O)CCl)N3[C@@H]1O","inchiKey":"LAHDERDHXJFFJU-RVPOWFKMSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LORAJMINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Lorajmine"],"childChemblIds":["CHEMBL3989784"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL3989763","canonicalSmiles":"CO[C@@H]1O[C@H](CO)[C@@H](O[C@@H]2O[C@H](CO)[C@@H](O[C@@H]3O[C@H](CO)[C@@H](O[C@@H]4O[C@H](CO)[C@@H](O[C@@H]5O[C@H](CO)[C@@H](O[C@@H]6O[C@H](C(=O)O)[C@@H](O[C@@H]7O[C@H](CO)[C@@H](O[C@@H]8O[C@H](CO)[C@@H](OC)[C@H](OC(C)=O)[C@@H]8O)[C@H](OC(C)=O)[C@@H]7O)[C@H](OC(C)=O)[C@@H]6O)[C@H](OC(C)=O)[C@@H]5O)[C@@H](O)[C@@H]4NC(C)=O)[C@H](OC(C)=O)[C@@H]3O)[C@H](OC(C)=O)[C@@H]2O)[C@H](OC(C)=O)[C@@H]1O","inchiKey":"XOYXESIZZFUVRD-YGGZJJQXSA-N","drugType":"Oligosaccharide","blackBoxWarning":false,"name":"ACEMANNAN","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Carraklenz wound & skin cleanser","Carrisyn","Snow & sun sports gel"],"synonyms":["Acemannan","Polymanoacetate"],"count":1,"description":"Oligosaccharide drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL3989872","canonicalSmiles":"C[C@@H](O)[C@H](N)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@@]1(Cc1ccccc1)C(=O)N[C@H](C(N)=O)[C@@H](C)O","inchiKey":"DVBUEXCIEIAXPM-PJUQSVSOSA-N","drugType":"Protein","blackBoxWarning":false,"name":"APIMOSTINEL","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Apimostinel","NRX-1074","Nrx-1074"],"crossReferences":{"drugbank":["DB11784"]},"count":2,"linkedTargets":{"rows":["ENSG00000183454","ENSG00000161509","ENSG00000273079","ENSG00000116032","ENSG00000105464","ENSG00000176884","ENSG00000198785"],"count":7},"linkedDiseases":{"rows":["MONDO_0002009","EFO_0000692"],"count":2},"description":"Protein drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL3990046","drugType":"Gene","blackBoxWarning":false,"name":"ELIVALDOGENE TAVALENTIVEC","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Elivaldogene tavalentivec","Lenti-D","Lenti-D Drug Product"],"count":10,"description":"Gene drug with a maximum clinical trial phase of II (across all indications) and has 10 investigational indications."}
{"id":"CHEMBL400754","canonicalSmiles":"CC1CCN(c2ccc(CO)cc2NC(=O)c2ccc(C#N)o2)CC1","inchiKey":"NNPCFFIJVKYGHR-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL400754","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07167"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4101487","canonicalSmiles":"O=C(O)c1ccc([C@H]2C[C@@H](NC(=O)C3(c4ccc5c(c4)OC(F)(F)O5)CC3)c3ccc(OC(F)F)cc3O2)cc1","inchiKey":"QVDYQHXNAQHIKH-TZIWHRDSSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GALICAFTOR","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ABBV-2222","GLPG-2222","GLPG2222","Galicaftor","Glpg2222"],"crossReferences":{"drugbank":["DB14894"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL418471","canonicalSmiles":"CCNC(=O)/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C","inchiKey":"WKYDOCGICAMTKE-NBIQJRODSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL418471","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB03917"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4297186","canonicalSmiles":"CN(C)Cc1ccc(CSCCNC(=C[N+](=O)[O-])NCc2ccc3c(c2)OCO3)o1","inchiKey":"HXRSXEDVVARPHP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NIPEROTIDINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Niperotidine"],"crossReferences":{"drugbank":["DB13760"]},"count":2,"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4297187","canonicalSmiles":"COCCNCCc1cccc(Nc2ncc3c(n2)-c2ccccc2[C@H](c2ccccc2F)C3)c1","inchiKey":"KPJDVVCDVBFRMU-AREMUKBSSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DERAZANTINIB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ARQ 087","ARQ087","Arq-087","Derazantinib"],"crossReferences":{"drugbank":["DB14889"]},"childChemblIds":["CHEMBL4298156"],"count":3,"linkedTargets":{"rows":["ENSG00000066468","ENSG00000068078","ENSG00000077782","ENSG00000160867"],"count":4},"linkedDiseases":{"rows":["EFO_0000616","EFO_0000503","EFO_0008528","EFO_1001961"],"count":4},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL4297287","canonicalSmiles":"COc1ccc([C@H]2CNC(=O)[C@H](Cc3cccc(C)c3)C2)cc1OC1CCCC1","inchiKey":"ABEJDMOBAFLQNJ-NHCUHLMSSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"HT-0712","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BLX-028914","Blx-028914","Ht-0712","IPL-455903","OX-914"],"crossReferences":{"drugbank":["DB11650"]},"count":2,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4297305","canonicalSmiles":"Nc1ncnc2c1ncn2CCNCCCCCO","inchiKey":"CVPTTZZCRDVGSU-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NB-001","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["HTS-09836","NB001","Nb-001"],"crossReferences":{"drugbank":["DB12716"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL4297311","canonicalSmiles":"COc1cc(Cl)ccc1[C@H]1c2[nH]c3cccc(F)c3c2C2(CC2)CN1C(C)=O","inchiKey":"ZBQMTQGDBFZUBG-NRFANRHFSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ONO-2952","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Ono-2952"],"crossReferences":{"drugbank":["DB14802"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL4297353","canonicalSmiles":"CCCS(=O)(=O)N1CCN(Cc2ccc(NC(=O)c3ccc(-c4cc(NC(=O)C5CC5)ccc4OC(F)(F)F)cc3)cc2)CC1","inchiKey":"MAQDQJWCSSCURR-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AZD-7295","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AZD7295","Azd 7295","Azd-7295","Azd7295"],"crossReferences":{"drugbank":["DB12724"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4297429","canonicalSmiles":"C[C@H](O)[C@@H](O)[C@@H](O)[C@H](F)C=O","inchiKey":"SQTFKIKSQNCWGJ-KCDKBNATSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"2-FLUOROFUCOSE","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["2-fluorofucose","Sgn-2ff"],"crossReferences":{"drugbank":["DB15302"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4297449","canonicalSmiles":"CC(C)N1CCC(N2CCCN(c3cccc(C(=O)Nc4ccncc4)n3)CC2)CC1","inchiKey":"XNUNVQKARNSSEO-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"USL-311","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["USL311","Usl 311","Usl-311","Usl311"],"crossReferences":{"drugbank":["DB15265"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4297462","canonicalSmiles":"COc1ccc2c(c1)[C@]1(C[C@H]1c1ccc3c(/C=C/c4ccc(CN5C[C@H](C)O[C@H](C)C5)cc4)n[nH]c3c1)C(=O)N2.O=C(O)/C=C/C(=O)O","inchiKey":"AQCDFVLWUWJREO-WQVJSASDSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CFI-400945","maximumClinicalTrialPhase":2,"parentId":"CHEMBL3408947","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CFI-400945","CFI-400945 FUMARATE","Cfi 400945","Cfi-400945","Cfi-400945 fumarate"],"count":3,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL4297497","canonicalSmiles":"NCc1ccc2c(c1)nc(CN1C(=O)C3(CC3)c3ccc(F)cc31)n2CCCC(F)(F)F","inchiKey":"JOPCJJSYRPUEDS-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"RV-521","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["RV-521","RV521","Rv-521","Rv521","Sisunatovir"],"crossReferences":{"drugbank":["DB15674"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL4297613","canonicalSmiles":"O=C(O)c1ccnc(N2CC(O)(c3ccc(OCc4c(-c5c(Cl)cccc5Cl)noc4C4CC4)cc3Cl)C2)c1","inchiKey":"KZSKGLFYQAYZCO-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CILOFEXOR","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Cilofexor","GS 9674","GS-9674","Gs-9674","PX-104","PX104"],"crossReferences":{"drugbank":["DB15168"]},"count":3,"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL4297756","drugType":"Antibody","blackBoxWarning":false,"name":"FREMANEZUMAB","yearOfFirstApproval":2018,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Ajovy"],"synonyms":["Fremanezumab","Fremanezumab-vfrm","LBR-101","PF-04472429","RN-307","RN307","TEV-48125","Tev-48125"],"crossReferences":{"DailyMed":["fremanezumab-vfrm"]},"count":3,"approvedIndications":["EFO_0003821"],"linkedTargets":{"rows":["ENSG00000110680","ENSG00000175868"],"count":2},"linkedDiseases":{"rows":["EFO_0005687","EFO_0003821","EFO_0008507","EFO_0003843"],"count":4},"description":"Antibody drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2018 and is indicated for migraine disorder and has 2 investigational indications."}
{"id":"CHEMBL4297792","drugType":"Unknown","blackBoxWarning":false,"name":"MYRCLUDEX B","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Myrcludex b"],"count":3,"description":"Unknown drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL4297860","drugType":"Antibody","blackBoxWarning":false,"name":"TILAVONEMAB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ABBV-8E12","Abbv-8e12","Tilavonemab"],"count":2,"description":"Antibody drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4297921","drugType":"Small molecule","blackBoxWarning":false,"name":"CARBOMER HOMOPOLYMER TYPE B (ALLYL PENTAERYTHRITOL CROSSLINKED)","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Carbomer homopolymer type b (allyl pentaerythritol crosslinked)","Carbopol 974"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4297965","drugType":"Unknown","blackBoxWarning":false,"name":"GSK-1614235","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["DSP-3235","DSP-3235 SEBACATE","GSK-1614235","GSK-16142353 SEBACATE","GSK1614235","Gsk-1614235","Gsk1614235","KGA-3235","KGA-3235 SEBACATE","KWA-0711 SEBACATE"],"count":1,"description":"Unknown drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4298010","drugType":"Enzyme","blackBoxWarning":false,"name":"VELMANASE ALFA","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Lamazym","Velmanase alfa"],"count":1,"description":"Enzyme drug with a maximum clinical trial phase of IV and has 1 investigational indication."}
{"id":"CHEMBL4303174","canonicalSmiles":"O.O=P(O)(O)C(O)(Cc1cccnc1)P(=O)(O)O","inchiKey":"SASLGGGHGGSNGY-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL4303174","maximumClinicalTrialPhase":0,"parentId":"CHEMBL923","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4303265","canonicalSmiles":"COc1cc(/C=C/C(=O)N2CCN(CC(=O)N3CCCC3)CC2)cc(OC)c1OC.O=C(O)/C=C\\C(=O)O","inchiKey":"XSTJTOKYCAJVMJ-GVTSEVKNSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL4303265","maximumClinicalTrialPhase":0,"parentId":"CHEMBL1874750","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4303454","canonicalSmiles":"C[C@@H](O)[C@H]1C(=O)N2C(C(=O)O)=C(S[C@@H]3CN[C@H](CNS(N)(=O)=O)C3)[C@H](C)[C@H]12.O","inchiKey":"NTUBEBXBDGKBTJ-WGLOMNHJSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL4303454","maximumClinicalTrialPhase":0,"parentId":"CHEMBL491571","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL442218","canonicalSmiles":"O=C1N[C@H](C(=O)O)CS1","inchiKey":"BMLMGCPTLHPWPY-REOHCLBHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PROCYSTEINE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["L-2-oxo-4-thiazolidinecarboxylic acid","Procysteine"],"crossReferences":{"drugbank":["DB12224"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL443014","canonicalSmiles":"COC(COC(N)=O)C1=C(N2CC2)C(=O)C(C)=C(N2CC2)C1=O","inchiKey":"SHHKQEUPHAENFK-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CARBOQUONE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Carboquone"],"crossReferences":{"PubChem":["144206299","423331","92763414"],"drugbank":["DB13677"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL444172","canonicalSmiles":"O[C@@H](COc1cccc2ncccc12)CN1CCN([C@@H]2c3ccccc3[C@@H]3[C@H](c4ccccc42)C3(F)F)CC1","inchiKey":"IHOVFYSQUDPMCN-DBEBIPAYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ZOSUQUIDAR","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Zosuquidar"],"crossReferences":{"Wikipedia":["Zosuquidar"],"drugbank":["DB06191"]},"childChemblIds":["CHEMBL2074689"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL447","canonicalSmiles":"C=CCC1(C(C)CCC)C(=O)NC(=O)NC1=O","inchiKey":"KQPKPCNLIDLUMF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SECOBARBITAL","yearOfFirstApproval":1950,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["France"," Norway"],"classes":["Misuse"],"year":1980},"tradeNames":["Seconal"],"synonyms":["Meballymal","Secobarbital"],"crossReferences":{"DailyMed":["secobarbital%20sodium"],"Wikipedia":["Secobarbital"],"drugbank":["DB00418"],"chEBI":["9073"]},"childChemblIds":["CHEMBL1200903"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1950. It was withdrawn in France and  Norway initially in 1980 due to Misuse."}
{"id":"CHEMBL4594338","drugType":"Oligonucleotide","blackBoxWarning":false,"name":"NEDOSIRAN SODIUM","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["DCR-PHXC","Dcr-phxc","Nedosiran sodium"],"count":1,"description":"Oligonucleotide drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL4594359","drugType":"Unknown","blackBoxWarning":false,"name":"PALTUSOTINE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Paltusotine"],"count":1,"description":"Unknown drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL4594582","drugType":"Unknown","blackBoxWarning":false,"name":"NZV-930","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["NZV-930","NZV930","Nzv-930","Nzv930","SRF-373"],"count":1,"description":"Unknown drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL46294","canonicalSmiles":"Nc1nc(=O)c2c([nH]1)NCC(CNc1ccc(C(=O)N[C@@H](CCC(=O)O)C(=O)O)cc1)=N2","inchiKey":"OZRNSSUDZOLUSN-LBPRGKRZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DIHYDROFOLIC ACID","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Dihydrofolic acid"],"crossReferences":{"Wikipedia":["Dihydrofolic_acid"],"drugbank":["DB02015"],"chEBI":["15633"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL46917","canonicalSmiles":"CNC(=O)Oc1cccc2ccccc12","inchiKey":"CVXBEEMKQHEXEN-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CARBARIL","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Carylderm","Clinicide","Derbac","Derbac-c","Suleo-c"],"synonyms":["Carbaril","Carbaryl","ENT-23969"],"crossReferences":{"PubChem":["144204545","144209034","144211171","170465695","17389992","26730497","26752735","50105386"],"Wikipedia":["Carbaryl"],"chEBI":["3390"]},"description":"Small molecule drug with a maximum clinical trial phase of IV."}
{"id":"CHEMBL473417","canonicalSmiles":"CS(=O)(=O)c1ccc(C(=O)Nc2ccc(Cl)c(-c3ccccn3)c2)c(Cl)c1","inchiKey":"BPQMGSKTAYIVFO-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"VISMODEGIB","yearOfFirstApproval":2012,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Erivedge"],"synonyms":["GDC-0449","NSC-747691","Vismodegib"],"crossReferences":{"DailyMed":["vismodegib"],"drugbank":["DB08828"],"chEBI":["66903"]},"childChemblIds":["CHEMBL4129312","CHEMBL4125998","CHEMBL4127241"],"count":22,"approvedIndications":["EFO_0000616","EFO_0004193","EFO_0000311"],"linkedTargets":{"rows":["ENSG00000128602"],"count":1},"linkedDiseases":{"rows":["MONDO_0018648","EFO_0000616","EFO_0003897","EFO_0002618","MONDO_0044903","EFO_0000768","MONDO_0008170","EFO_1001465","MONDO_0007254","MONDO_0005341","EFO_0000222","EFO_0002939","EFO_0000305","MONDO_0008315","EFO_0000311","EFO_1001480","EFO_1000044","Orphanet_377","EFO_0002517","EFO_0000702","EFO_0000673","EFO_0000326","EFO_0001378","EFO_0004193","Orphanet_2495","EFO_0000519"],"count":26},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2012 and has 3 approved and 19 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL487","canonicalSmiles":"CC/C(=C(/c1ccc(OCCN(C)C)cc1)c1cccc(O)c1)c1ccccc1","inchiKey":"ZQZFYGIXNQKOAV-OCEACIFDSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DROLOXIFENE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["3-hydroxytamoxifen","Droloxifene","E-Droloxifene","FK-435","Fk-435","K-21060E","K060","K060E"],"crossReferences":{"chEBI":["34731"]},"childChemblIds":["CHEMBL2105786"],"description":"Small molecule drug with a maximum clinical trial phase of III."}
{"id":"CHEMBL490961","canonicalSmiles":"CNc1ccc(Sc2nncn2C)cc1C(=O)Nc1nc(C)cs1","inchiKey":"XRJAKERBMMBUGR-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL490961","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08118"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL495224","canonicalSmiles":"N[C@@H](CCCO)C(=O)O","inchiKey":"CZWARROQQFCFJB-BYPYZUCNSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"L-5-Hydroxynorvaline","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["L-5-Hydroxynorvaline"],"crossReferences":{"drugbank":["DB03105"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL495597","canonicalSmiles":"CCN(CC)C(=O)Cc1cccc(NS(=O)(=O)c2cccc(Cl)c2C)n1","inchiKey":"JNWQLOFSMUGRNY-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL495597","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07056"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL497939","canonicalSmiles":"O=c1cccc2n1C[C@@H]1CNC[C@H]2C1","inchiKey":"ANJTVLIZGCUXLD-DTWKUNHWSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CYTISINICLINE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Tabex"],"synonyms":["6039 Sopharma","Cytisine","Cytisinicline","NSC-407282"],"crossReferences":{"PubChem":["11112361","11114058","26752181","477069","56463106"],"Wikipedia":["Cytisine"],"drugbank":["DB09028"],"chEBI":["4055"]},"count":2,"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL499017","canonicalSmiles":"O=S(=O)(Oc1ccc(Cl)cc1)c1ccc(Cl)cc1","inchiKey":"RZXLPPRPEOUENN-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHLORFENSON","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Chlorfenson"],"crossReferences":{"PubChem":["144208461","144213059"],"drugbank":["DB05377"],"chEBI":["82155"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL502182","canonicalSmiles":"COc1cccc(-c2c(C)n(Cc3c(F)cccc3C(F)(F)F)c(=O)n(C[C@H](NCCCC(=O)[O-])c3ccccc3)c2=O)c1F.[Na+]","inchiKey":"DQYGXRQUFSRDCH-UQIIZPHYSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"ELAGOLIX SODIUM","yearOfFirstApproval":2018,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1208155","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Orilissa"],"synonyms":["Elagolix sodium","Elagolix sodium salt","NBI-56418 NA","NBI-56418-NA"],"crossReferences":{"DailyMed":["elagolix%20sodium"]},"count":1,"approvedIndications":["EFO_0001065"],"linkedTargets":{"rows":["ENSG00000109163"],"count":1},"linkedDiseases":{"rows":["EFO_0001065"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 2018 and is indicated for endometriosis."}
{"id":"CHEMBL50514","canonicalSmiles":"COc1cc(N(C)Cc2cnc3nc(N)nc(N)c3c2C)cc(OC)c1OC","inchiKey":"PEGMMEYCSOZKIT-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL50514","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB02104"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL513425","canonicalSmiles":"N[C@@H](CC(=O)N1CCCCCN1C(=O)c1ccccc1)Cc1cc(F)c(F)cc1F","inchiKey":"XXRHRPGYYNOBHO-QGZVFWFLSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL513425","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08051"]},"childChemblIds":["CHEMBL539611"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL515564","canonicalSmiles":"CCCCCCCCCCCCCCCCOCCCOP(=O)(O)CO[C@H](C)Cn1cnc2c(N)ncnc21","inchiKey":"SCTJKHUUZLXJIP-RUZDIDTESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TENOFOVIR EXALIDEX","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CMX-157","CMX157","Cmx157","Hexadecyloxypropyl Tenofovir","Tenofovir exalidex"],"crossReferences":{"drugbank":["DB14925"]},"count":2,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL519504","canonicalSmiles":"CO[C@@H](Cc1ccc(OCCc2nc(-c3ccccc3)oc2C)c2ccsc12)C(=O)O","inchiKey":"DAYKLWSKQJBGCS-NRFANRHFSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ALEGLITAZAR","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Aleglitazar","R-1439","R1439","RO-0728804","RO0728804","Ro-0728804"],"crossReferences":{"Wikipedia":["Aleglitazar"],"drugbank":["DB08915"]},"count":1,"linkedTargets":{"rows":["ENSG00000186951","ENSG00000132170"],"count":2},"linkedDiseases":{"rows":["EFO_0001360"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL524266","canonicalSmiles":"Nc1nccc(-c2cc3c([nH]2)[C@@H](CCF)CNC3=O)n1","inchiKey":"LCBAQTCTQXHTJG-ZETCQYMHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL524266","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07149"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL540","canonicalSmiles":"c1c[nH]cn1","inchiKey":"RAXXELZNTBOGNW-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"IMIDAZOLE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Imidazole"],"crossReferences":{"PubChem":["144208702","17388974"],"Wikipedia":["Imidazole"],"drugbank":["DB03366"],"chEBI":["16069"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL557983","canonicalSmiles":"COc1ccc(-n2nnnc2C(F)(F)F)cc1CN[C@H]1CCCN[C@H]1c1ccccc1.Cl.Cl","inchiKey":"YVNRXILPJNISEM-FFUVTKDNSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"VOFOPITANT DIHYDROCHLORIDE","maximumClinicalTrialPhase":0,"parentId":"CHEMBL522302","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["GR-205171","GR205171A","Vofopitant dihydrochloride"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL56337","canonicalSmiles":"CC(/C=C1\\SC(=S)N(CC(=O)O)C1=O)=C\\c1ccccc1","inchiKey":"CHNUOJQWGUIOLD-NFZZJPOKSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"EPALRESTAT","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Epalrestat"],"crossReferences":{"PubChem":["26664249","26758035"],"Wikipedia":["Epalrestat"],"drugbank":["DB15293"],"chEBI":["31539"]},"childChemblIds":["CHEMBL4297277"],"count":1,"linkedTargets":{"rows":["ENSG00000085662"],"count":1},"linkedDiseases":{"rows":["EFO_1000783","MONDO_0007254"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL66092","canonicalSmiles":"CCN(C(=O)c1c(O)c2c(Cl)cccc2n(C)c1=O)c1ccccc1","inchiKey":"GKWPCEFFIHSJOE-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LAQUINIMOD","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ABR-215062","ABR-215062 FREE ACID","Laquinimod","TV-5600 FREE ACID"],"crossReferences":{"PubChem":["174007071"],"Wikipedia":["Laquinimod"],"drugbank":["DB06685"]},"childChemblIds":["CHEMBL2103814"],"count":7,"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 7 investigational indications."}
{"id":"CHEMBL73303","canonicalSmiles":"NS(=O)(=O)c1ccc(Nc2nccc(-c3cnc4ccccn34)n2)cc1","inchiKey":"NKORVPQBJCGYEC-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL73303","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB02197"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL812","canonicalSmiles":"CN(C)C(=O)Oc1ccc[n+](C)c1.[Br-]","inchiKey":"VNYBTNPBYXSMOO-UHFFFAOYSA-M","drugType":"Small molecule","blackBoxWarning":true,"name":"PYRIDOSTIGMINE BROMIDE","yearOfFirstApproval":1955,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1115","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Kalymin","Mestinon","Mestinon 10","Mestinon ret","Pyridostigmine bromide","Regonal","Regonol"],"synonyms":["NSC-679759","Pyridostigmine Bromide","Pyridostigmine bromide","RO-1-5130"],"crossReferences":{"DailyMed":["pyridostigmine%20bromide"],"PubChem":["144204818","170464878","26747656","50106936","518187","56422100","855974"]},"count":6,"approvedIndications":["EFO_0004991"],"linkedTargets":{"rows":["ENSG00000087085"],"count":1},"linkedDiseases":{"rows":["Orphanet_365","MONDO_0100096","EFO_0003144","EFO_0002508","EFO_0005252","EFO_0004991","EFO_0005251"],"count":7},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1955 and is indicated for myasthenia gravis and has 5 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL86554","canonicalSmiles":"CCCCCCCC/C=C/CCCCCCCC(N)=O","inchiKey":"FATBGEAMYMYZAF-MDZDMXLPSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL86554","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB03784"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL87580","canonicalSmiles":"CC(C)(C)c1cc(NC(=O)Nc2ccccc2)n(-c2cccc(N)c2)n1","inchiKey":"DHNYNLNKNQJSHF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL87580","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB06883"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL87697","canonicalSmiles":"N#Cc1ccccc1OCC(O)CNCCNC(=O)Cc1ccc(O)cc1","inchiKey":"YARKMNAWFIMDKV-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"EPANOLOL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Epanolol","ICI 141,292"],"crossReferences":{"drugbank":["DB13757"],"chEBI":["4800"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
